Division of Strategic Planning and Evaluation Research Program on Emerging and Re-emerging Infectious Diseases

Outline

Key Fields Innovative Drug Discovery and Development Project
R&D phase Basic Study, Applied Study, Nonclinical Study/Pre-clinical Study, Clinical Trials, Post Marketing, None
Contact
Division of Infectious Disease Research, Department of Innovative Drug Discovery and Development
TEL: +81-3-6870-2226

The aim of this program is to strengthen comprehensively the countermeasures against infectious diseases to prevent people in Japan and the world from infectious diseases; thus, contributing to overcome the public health problems. To achieve this issue, the program  supports to promote domestic and global infectious disease R&D, including basic research, basic manufacturing technologies, and research for practical applications (such as developing the diagnostics, treatments, and preventions) that contribute to control infectious diseases.

Research Program on Emerging and Re-emerging Infectious Diseases

List of Research Projects

Management and Evaluation Framework

PS (Program Supervisor)

  • KAKU Mitsuo, Professor, Tohoku Medical and Pharmaceutical University
PO (Program Officer)
  • KANDA Tadahito, former Team Leader, RIKEN
  • HIRAI Keiji, Advisor, KYORIN Pharmaceutical Co.
  • HIRAYAMA Toshiya, Professor Emeritus, Nagasaki University
  • HOSHINO Kazuki, Vice President, Technology Department, Daiichi Sankyo Biotech Co.
  • MORI Toru, Director Emeritus, The Research Institute of Tuberculosis, Japan Anti-tuberculosis Association


Therapeutic drug development program for COVID-19

PS (Program Supervisor)

  • MATSUMOTO Tetsuya, Professor, International University of Health and Welfare
PO (Program Officer)
  • AKASHI Toshi, Professor, Kyushu University of Health and Welfare
  • TAWARA Shuichi, Professor, Okayama University of Science
  • YAMAGUCHI Teruhide, Professor, Kanazawa Institute of Technology
  • YAMASHITA Makoto, Professor, Aichi Medical University

Last updated 2020.10.20